WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences:
A live webcast of the fireside chats will be available through the investor relations section of the Company’s website at ir.discmedicine.com and an archived replay will be available after the event.
About Disc Medicine
Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.
Media Contact
Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com
Investor Relations Contact
Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com
NEW YORK, Sept. 9, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape-…
[New functionality brings support for the entire point-of-care imaging workflow, from admission to final report.…
Elevate CTO and co-founder honored with Excellence in Benefits award DENVER, Sept. 9, 2024 /PRNewswire/…
Workplace violence, high RN turnover, and dangerous nurse staffing conditions plague hospital MARLBOROUGH, Mass., Sept.…
FDA-authorized RelieVRx now a covered treatment for Highmark's commercial members experiencing chronic low back pain…
Largest event in quality group's 34-year history will explore quality's futureWASHINGTON, D.C. / ACCESSWIRE /…